Published in Neuro Oncol on November 26, 2013
Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography. Sci Transl Med (2015) 0.99
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. Neuro Oncol (2015) 0.95
The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers (Basel) (2014) 0.91
Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med (2015) 0.90
Assessment and treatment relevance in elderly glioblastoma patients. Neuro Oncol (2014) 0.90
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. Neuro Oncol (2016) 0.85
Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer. Cell Death Dis (2014) 0.85
Label-free delineation of brain tumors by coherent anti-Stokes Raman scattering microscopy in an orthotopic mouse model and human glioblastoma. PLoS One (2014) 0.84
5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns. Biomed Res Int (2014) 0.84
Glioblastoma resection: in search of a threshold between worthwhile and futile. Neuro Oncol (2014) 0.83
Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival. PLoS One (2015) 0.81
The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol (2014) 0.80
Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery. Mol Imaging Biol (2016) 0.79
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. Neurotherapeutics (2017) 0.78
The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible. Cost Eff Resour Alloc (2016) 0.78
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients. Neuro Oncol (2016) 0.78
Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes. Cell Rep (2016) 0.77
Strategy of Surgical Resection for Glioma Based on Intraoperative Functional Mapping and Monitoring. Neurol Med Chir (Tokyo) (2015) 0.77
Glioblastoma recurrence patterns near neural stem cell regions. Radiother Oncol (2015) 0.77
Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas. Ther Deliv (2015) 0.77
Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Br J Neurosurg (2015) 0.77
Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells. Theranostics (2016) 0.77
Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study. PLoS One (2016) 0.75
Surgical complications following malignant brain tumor surgery: An analysis of 2002-2011 data. Clin Neurol Neurosurg (2015) 0.75
Network Plasticity and Intraoperative Mapping for Personalized Multimodal Management of Diffuse Low-Grade Gliomas. Front Surg (2017) 0.75
Role of Glioblastoma Craniotomy Related to Patient Survival: A 10-Year Survey in a Tertiary Care Hospital in Pakistan. J Neurol Surg B Skull Base (2016) 0.75
Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma. Cancer Sci (2016) 0.75
Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas. Onco Targets Ther (2016) 0.75
The battle for the brain: Brain tumor-initiating cells vs. microglia/macrophages. Oncoimmunology (2014) 0.75
The need to continually redefine the goals of surgery for glioblastoma. Neuro Oncol (2014) 0.75
Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization. Oncogene (2017) 0.75
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study. Oncotarget (2017) 0.75
Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival. J Neurooncol (2017) 0.75
Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors. Curr Treat Options Oncol (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol (2010) 14.79
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg (2001) 11.58
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol (2006) 11.56
The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol (2002) 8.62
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst (1993) 7.87
An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32
Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol (2003) 5.40
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery (2008) 5.03
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol (2004) 3.25
Factors influencing survival in high-grade gliomas. Semin Oncol (2003) 2.93
Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg (2009) 2.70
Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery (1998) 2.36
Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) (2006) 2.13
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg (2010) 2.11
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg (2009) 1.91
Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery (2009) 1.79
The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol (1999) 1.71
The human subventricular zone: a source of new cells and a potential source of brain tumors. Exp Neurol (2007) 1.59
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol (2006) 1.50
A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg (2010) 1.47
Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol (2008) 1.42
Intraoperative stimulation techniques for functional pathway preservation and glioma resection. Neurosurg Focus (2010) 1.25
Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol (2010) 1.24
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery (2005) 1.23
Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg (2012) 1.18
Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme--a quantitative radiological analysis. Neuroradiology (2005) 1.15
Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol (2007) 1.14
Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. Radiother Oncol (2000) 0.95
The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival. Neurol Res (2011) 0.93
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Universal definition of myocardial infarction. Circulation (2007) 11.69
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron (2006) 5.34
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91
Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg (2006) 3.73
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res (2010) 3.56
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 3.47
A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia (2008) 3.28
The minipterional craniotomy for anterior circulation aneurysms: initial experience with 72 patients. Neurosurgery (2014) 3.26
Patterns of care for adults with newly diagnosed malignant glioma. JAMA (2005) 3.08
Achieving the National Quality Forum's "Never Events": prevention of wrong site, wrong procedure, and wrong patient operations. Ann Surg (2007) 3.04
Autoimmune hypophysitis. Endocr Rev (2005) 2.86
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg (2009) 2.70
Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65
Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res (2011) 2.59
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys (2013) 2.28
Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg (2007) 2.26
Seizure control for patients undergoing meningioma surgery. World Neurosurg (2012) 2.19
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg (2010) 2.11
Preoperative charlson comorbidity score predicts postoperative outcomes among older intracranial meningioma patients. World Neurosurg (2011) 2.09
The transconjunctival transorbital approach: a keyhole approach to the midline anterior skull base. World Neurosurg (2012) 2.09
Craniofacial resection of midline anterior skull base malignancies: a reassessment of outcomes in the modern era. World Neurosurg (2011) 2.08
Integrative model of genomic factors for determining binding site selection by estrogen receptor-α. Mol Syst Biol (2010) 2.04
"Any possible restoration of function could not occur": Harvey Cushing and the early description of brain death. World Neurosurg (2011) 2.03
Intraoperative changes in transcranial motor evoked potentials and somatosensory evoked potentials predicting outcome in children with intramedullary spinal cord tumors. J Neurosurg Pediatr (2014) 2.03
Diagnosis and management of sacral Tarlov cysts. Case report and review of the literature. Neurosurg Focus (2003) 2.01
En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine (2005) 1.99
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg (2009) 1.91
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery (2009) 1.79
Intraoperative ultrasonography as a guide to patient selection for duraplasty after suboccipital decompression in children with Chiari malformation Type I. J Neurosurg Pediatr (2008) 1.75
Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery (2008) 1.72
Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg (2012) 1.72
Disparities in access to neuro-oncologic care in the United States. Arch Surg (2010) 1.67
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res (2012) 1.67
Efficacy of intravenous patient-controlled analgesia after supratentorial intracranial surgery: a prospective randomized controlled trial. Clinical article. J Neurosurg (2009) 1.64
Combined microsurgical and endovascular management of complex intracranial aneurysms. Neurosurgery (2003) 1.64
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2005) 1.63
Targeted therapy for brain tumours. Nat Rev Drug Discov (2004) 1.63
Establishment and characterization of a primary human chordoma xenograft model. J Neurosurg (2012) 1.60
Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer (2008) 1.56
Introducer catheter for fiberoptic intubation does exist. Anesth Analg (2006) 1.56
The extended retrosigmoid approach for neoplastic lesions in the posterior fossa: technique modification. Neurosurg Rev (2010) 1.54
Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. J Neurosurg (2002) 1.54
Predictors of length of stay in patients having elective colorectal surgery within an enhanced recovery protocol. Int J Surg (2010) 1.52
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell (2010) 1.51
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer. Clin Cancer Res (2006) 1.50
Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol (2006) 1.50
A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg (2010) 1.47
Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery (2004) 1.47
Postoperative mortality after surgery for brain tumors by patient insurance status in the United States. Arch Surg (2012) 1.47
Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg (2003) 1.47
Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf (2007) 1.46
Role of cancer stem cells in spine tumors: review of current literature. Neurosurgery (2012) 1.43
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Soft-tissue imaging with C-arm cone-beam CT using statistical reconstruction. Phys Med Biol (2014) 1.42
Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol (2008) 1.42
Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin. J Neurosurg (2011) 1.42
Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. Leuk Lymphoma (2004) 1.41
Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc (2011) 1.41
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J Clin Oncol (2009) 1.41
Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg (2013) 1.41
Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs (2004) 1.40